Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
about
Cancer Metabolism: A Modeling PerspectiveDietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancerTumor Metabolism, the Ketogenic Diet and β-Hydroxybutyrate: Novel Approaches to Adjuvant Brain Tumor TherapyMUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.Tumor Cells Growth and Survival Time with the Ketogenic Diet in Animal Models: A Systematic ReviewReprogramming induced by isoliquiritigenin diminishes melanoma cachexia through mTORC2-AKT-GSK3β signalingBeneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation.Famine versus feast: understanding the metabolism of tumors in vivo.Non-Toxic Metabolic Management of Metastatic Cancer in VM Mice: Novel Combination of Ketogenic Diet, Ketone Supplementation, and Hyperbaric Oxygen Therapy.The Ketogenic Diet Does Not Affect Growth of Hedgehog Pathway Medulloblastoma in Mice.Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis.The Plasma Membrane Calcium Pump in Pancreatic Cancer Cells Exhibiting the Warburg Effect Relies on Glycolytic ATP.Leucine-rich diet alters the (1)H-NMR based metabolomic profile without changing the Walker-256 tumour mass in ratsMUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism.Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growthPancreatic cancer cell-derived IGFBP-3 contributes to muscle wastingThe 2-oxoglutarate analog 3-oxoglutarate decreases normoxic hypoxia-inducible factor-1α in cancer cells, induces cell death, and reduces tumor xenograft growth.Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities.Nuclear Magnetic Resonance metabolomics reveals an excretory metabolic signature of renal cell carcinoma.Premorbid obesity, but not nutrition, prevents critical illness-induced muscle wasting and weakness.The action of β-hydroxybutyrate on the growth, metabolism and global histone H3 acetylation of spontaneous mouse mammary tumours: evidence of a β-hydroxybutyrate paradoxT cell metabolic reprogramming and plasticity.GPR55 receptor antagonist decreases glycolytic activity in PANC-1 pancreatic cancer cell line and tumor xenografts.Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics.Regulation of hepatic stellate cell proliferation and activation by glutamine metabolismInactivation of HMGCL promotes proliferation and metastasis of nasopharyngeal carcinoma by suppressing oxidative stress.Fenofibrate Induces Ketone Body Production in Melanoma and Glioblastoma Cells.Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.Introduction: What to Eat When You Can't Eat.Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites.A ketogenic diet supplemented with medium-chain triglycerides enhances the anti-tumor and anti-angiogenic efficacy of chemotherapy on neuroblastoma xenografts in a CD1-nu mouse model.Correction: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.The influence of ketogenic therapy on the 5 R's of radiobiology.Glucose Limitation Alters Glutamine Metabolism in MUC1-Overexpressing Pancreatic Cancer Cells.Hypoxia-Mediated In Vivo Tumor Glucose Uptake Measurement and Analysis.Low ketolytic enzyme levels in tumors predict ketogenic diet responses in cancer cell lines in vitro and in vivo.MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.De Novo Lipid Synthesis Facilitates Gemcitabine Resistance through Endoplasmic Reticulum Stress in Pancreatic Cancer.
P2860
Q26770819-D1380327-B19E-4C31-B567-EE5FDC9B1BABQ28069088-560DAE10-70D7-48E1-A17F-A8787A515D17Q28069398-FE62855C-864D-4123-BA50-F632E09608CEQ33626753-2676D8B0-DC70-4659-A5C7-CECE2C7D0BE3Q33743850-7B68A442-B978-4BB6-A5CA-45A618830A33Q33798469-F763E59D-3EAE-4A75-8F62-8F116C644C5FQ34558255-362641E4-8713-465E-8895-488EDEB10A09Q35122371-EA3B6651-92A6-46F2-A2BD-37D5D9F551E8Q35660112-D8F9328A-0A39-494D-9D09-AA79F4D4B361Q35867273-42BB717E-BBD2-4BA3-B921-74450B3EAA80Q36012197-DCDBB300-4660-4447-86B0-8EAAFFE7757AQ36139808-E0102503-2334-42AB-A4A4-AFD6DF4A286DQ36156782-58A254F7-E2BA-412C-9039-2326D2B51701Q36326344-F5D10A51-D91D-4A86-818D-273996663CC0Q36562311-3501E244-0296-4669-A0A5-F88863EF4C88Q36686835-D87A59F0-C992-416B-9CC5-7AB9D1610924Q37167665-7F41BF41-5537-4252-A6FA-46E577FB887DQ37307454-CD46C5D9-E29D-40A6-B10B-3FB7211F8994Q37421650-BE132E9A-3E99-41D7-8570-1368110B014BQ37667505-0F7E7D7D-358B-4EEE-BD7B-B63DE76A3A10Q37673340-A7544087-B26F-4077-8845-3D0B4C54BB8BQ38567424-D9BB6C50-9B19-40AB-9B6C-D8BE1AAD3064Q38662813-7A470F83-8B6F-445A-814A-7F9FB87E5E05Q38807599-25DB1831-080D-45E9-A89B-255819CC4F51Q39126658-F3754F56-265C-4532-BA37-BB563F5919FEQ41349258-C7ED8944-2A91-4BF7-BC01-1D54D38EB17DQ41696827-468DAFB9-C14B-49E0-BBBC-9AEE6CC4B522Q41851340-7AF59936-E242-421F-ABB7-42AC40A5F7FAQ41989445-DE5AC225-5092-44C2-98D8-65331BD6DD70Q42054690-930D2DB6-AE9F-4A9B-808E-6EE2F5784C9FQ42132357-3FCCC821-6DEF-47BA-8536-1396B21860B5Q42371465-6EC3C03F-C7F7-4870-BD84-1E584B29AD55Q46771693-E1B9184E-5A8F-4F66-8B4A-C25F84B7775DQ47987478-49A5A8AC-909A-4E1C-AAEC-BFEDE0752254Q48237710-FFCB7716-875D-4A8F-BEC6-4BFD5AAFA710Q50057464-37BB9F35-7F4D-492D-A58B-5DA260613105Q50134199-4434745E-20BA-4060-8012-E900E60263D0Q50897000-A92CB49F-1BA2-420F-9632-473C20C594E6Q51010116-8C43554B-1F2A-414D-B687-F4CEC0D97D86Q51807216-435365EA-6682-4344-8501-EE842CE9B214
P2860
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@ast
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@en
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@nl
type
label
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@ast
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@en
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@nl
prefLabel
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@ast
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@en
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@nl
P2093
P2860
P356
P1433
P1476
Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia.
@en
P2093
Iraklis I Pipinos
Kamiya Mehla
Nina V Chaika
Pankaj K Singh
Prakash Radhakrishnan
Robert Powers
Surendra K Shukla
Teklab Gebregiworgis
Venugopal Gunda
P2860
P2888
P356
10.1186/2049-3002-2-18
P577
2014-09-01T00:00:00Z
P5875
P6179
1017413151